Wall Street analysts bullish on genetic testing firm Tempus AI

Wall Street brokerages started covering SoftBank Group-backed Tempus AI (TEM.O) on a bullish note on Tuesday, betting that the company's AI-powered library of clinical and molecular data could lead to more powerful diagnostic and test kits.